Jul 17, 2024 5:48 PM
BACK TO TOP
KSE100
81,155.60
1211.51
(1.52%)
ALLSHR
51,473.90
467.55
(0.92%)
KSE30
25,983.41
482.93
(1.89%)
KMI30
129,001.86
1856.38
(1.46%)
BKTI
21,319.12
336.96
(1.61%)
OGTI
17,614.14
347.58
(2.01%)
KMIALLSHR
35,852.95
403.59
(1.14%)
PSXDIV20
33,954.51
314.39
(0.93%)
UPP9
24,671.17
446.83
(1.84%)
NITPGI
19,764.91
399.78
(2.06%)
NBPPGI
22,058.52
446.82
(2.07%)
MZNPI
17,289.51
325.92
(1.92%)
JSMFI
23,008.33
585.32
(2.61%)
ACI
12,835.19
141.16
(1.11%)
JSGBKTI
22,916.69
235.29
(1.04%)
MII30
11,848.88
160.74
(1.38%)
HBLTTI
14,506.17
28-06-2024
18.76
(0.13%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.31.07
0.10
(0.32%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Jul 15, 2024 4:12 PM
REG
FUT
ODL
Open
31.20
High
31.81
Low
30.90
Volume
1,415,133
CIRCUIT BREAKER
28.12 — 34.02
DAY RANGE
30.90 — 31.81
52-WEEK RANGE
19.07 — 33.85
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
30.97
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM) **
8.83
1-Year Change *
28.60%
YTD Change *
30.88%
Last update: Mon, Jul 15, 2024 4:11 PM
Open
31.36
High
32.00
Low
31.15
Close
31.26
Change
0.19%
LDCP
31.20
Volume
242,500
Total Trades
223
CIRCUIT BREAKER
28.29 — 34.23
DAY RANGE
31.15 — 32.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Mon, Jun 3, 2024 8:00 AM
Open
0.00
High
0.00
Low
0.00
Close
30.84
Change
0.00%
LDCP
32.00
Volume
0
Total Trades
0
CIRCUIT BREAKER
28.96 — 35.04
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Tue, Jul 2, 2024 8:00 AM
Open
0.00
High
0.00
Low
0.00
Close
34.10
Change
0.00%
LDCP
32.59
Volume
0
Total Trades
0
CIRCUIT BREAKER
29.49 — 35.69
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Wed, Jul 6, 2022 3:21 PM
Open
32.52
High
32.99
Low
32.30
Close
32.49
Change
0.99%
LDCP
23.17
Volume
1,708
Total Trades
0
CIRCUIT BREAKER
20.85 — 25.49
DAY RANGE
32.30 — 32.99
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
7,098,289.48
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2024Transmission of Quarterly Report for the period ended View   PDF
Apr 26, 2024Financial Results for the quarter ended View   PDF
Mar 4, 2024Transmission of Quarterly Report for Period Ended View   PDF
Feb 29, 2024Financial Results for the Quarter Ended 2023-12-31 View   PDF
Oct 31, 2023Transmission of Quarterly Report for the Period Ended September 30, 2023 View   PDF
Oct 30, 2023Financial Results for the Quarter Ended September 30, 2023 View   PDF
Oct 6, 2023Transmission of Annual Report for the year ended 30-06-2023 View   PDF
Sep 28, 2023Financial Results for the year ended 30-06-2023 View   PDF
Apr 28, 2023Transmission of Quarterly Report for the Period ended March 31, 2023 View   PDF
Apr 28, 2023Financial Results for the 3rd Quarter ended March 31, 2023 View   PDF
DateTitleDocument
Apr 25, 2024Board Meeting in Progress View   
Apr 18, 2024Board Meeting View   
Feb 21, 2024Board Meeting View   
Oct 20, 2023Board Meeting View   
Oct 6, 2023Notice of Annual General Meeting View   PDF
Sep 21, 2023Board Meeting View   
May 29, 2023Results of Board Meeting 26-05-2023 View   PDF
May 26, 2023Emergent Board Meeting in Progress View   
May 25, 2023Board Meeting View   
Apr 20, 2023Board Meeting View   
DateTitleDocument
Jul 5, 2024Company Secretary View   
Jul 2, 2024Material Information View   PDF
May 15, 2024Material Information View   PDF
May 7, 2024Change of Company Secretary View   
May 7, 2024Material Information View   PDF
Nov 13, 2023Dispatch of Final Dividend Warrants View   PDF
Nov 8, 2023Material Information View   PDF
Sep 21, 2023Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Sep 21, 2023Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 2, 2023Corporate Briefing Session View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2023202220212020
Sales12,396,9839,779,8805,795,4043,527,625
Profit after Taxation657,984635,884351,768143,416
EPS2.882.883.6431.87
Q3 2024Q2 2024Q1 2024Q3 2023
Sales3,558,8743,275,1652,701,2282,688,728
Profit after Taxation211,345375,60194,45292,766
EPS0.931.640.410.41
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2023202220212020
Gross Profit Margin (%)12.1613.8313.4712.39
Net Profit Margin (%)5.316.506.074.07
EPS Growth (%)(20.88)(88.58)415.70
PEG(0.54)(0.11)

Payouts

DateFinancial ResultsDetailsBook Closure
September 28, 2023 4:07 PM30/06/2023(YR) 25%(F) (D) 20/10/2023 - 27/10/2023
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports